KFU. Card publication. Preclinical Research of Mesenchymal Stem Cell-Based Therapy for Ocular Diseases

KAZAN
FEDERAL UNIVERSITY

- RUS
- 中文
- ES

PRECLINICAL RESEARCH OF MESENCHYMAL STEM CELL-BASED THERAPY FOR OCULAR DISEASES

Form of presentation

International monographs

Year of publication

2022

��

��

Authors, employees of KFU

Aymaletdinov Aleksandr Maazovich, author

Zakirova Elena Yurevna, author

Malaneva Albina Gennadevna, author

Rizvanov Albert Anatolevich, author

Other authors

Rutland Catrin , author

Bibliographic description in the original language

Zakirova E. Handbook of Stem Cell Therapy / E. Zakirova, A. M. Aimaletdinov, A. G. Malanyeva, S. S. Rutland, and A. A. Rizvanov; K. H. Haider (ed.). - Springer Nature Singapore Pte Ltd, 2022.

Annotation

Mesenchymal stem cells (MSC) are specific cell types that enable tissue renewal within the body and are activated during the regeneration processes in response to injury. These cells are present in all human and animal tissues. In medical and biological research, MSCs are isolated and purified from the donor organism and cultured in vitro before use in the treatment of a variety of diseases and conditions associated with tissue damage and cell loss, including ocular lesions. This approach is called cell-based therapy or regenerative medicine. Despite the many existing therapeutic strategies in the area of cell therapy in relation to curing ocular diseases in recent years, advances and new regenerative therapy methods have also been developed and consolidated, giving us a new perspective.

Keywords

Stem cells, ocular disease, therapy.

URL

https://link.springer.com/referencework/10.1007/978-981-16-6016-0?page=1#toc

Please use this ID to quote from or refer to the card

https://repository.kpfu.ru/eng/?p_id=265061&p_lang=2

Resource files

File name	Size (MB)	Format
F_Zakirova2022_ReferenceWorkEntry_PreclinicalResearchOfMesenchym.pdf	0,33	pdf	show / download

Full metadata record

Field DC	Value	Language
dc.contributor.author	Aymaletdinov Aleksandr Maazovich	ru_RU
dc.contributor.author	Zakirova Elena Yurevna	ru_RU
dc.contributor.author	Malaneva Albina Gennadevna	ru_RU
dc.contributor.author	Rizvanov Albert Anatolevich	ru_RU
dc.contributor.author	Rutland Catrin	ru_RU
dc.date.accessioned	2022-01-01T00:00:00Z	ru_RU
dc.date.available	2022-01-01T00:00:00Z	ru_RU
dc.date.issued	2022	ru_RU
dc.identifier.citation	Zakirova E. Handbook of Stem Cell Therapy / E. Zakirova, A. M. Aimaletdinov, A. G. Malanyeva, �. S. Rutland, and A. A. Rizvanov; K. H. Haider (ed.). - Springer Nature Singapore Pte Ltd, 2022.	ru_RU
dc.identifier.uri	https://repository.kpfu.ru/eng/?p_id=265061&p_lang=2	ru_RU
dc.description.abstract	Mesenchymal stem cells (MSC) are specific cell types that enable tissue renewal within the body and are activated during the regeneration processes in response to injury. These cells are present in all human and animal tissues. In medical and biological research, MSCs are isolated and purified from the donor organism and cultured in vitro before use in the treatment of a variety of diseases and conditions associated with tissue damage and cell loss, including ocular lesions. This approach is called cell-based therapy or regenerative medicine. Despite the many existing therapeutic strategies in the area of cell therapy in relation to curing ocular diseases in recent years, advances and new regenerative therapy methods have also been developed and consolidated, giving us a new perspective.	ru_RU
dc.language.iso	ru	ru_RU
dc.subject	Stem cells	ru_RU
dc.subject	ocular disease	ru_RU
dc.subject	therapy.	ru_RU
dc.title	Preclinical Research of Mesenchymal Stem Cell-Based Therapy for Ocular Diseases	ru_RU
dc.type	International monographs	ru_RU